Prof. Dr. SEDAT ÇAPAR

Yayın Ağı

Makaleler 25

1. Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis

Uslu S., GÜLLE S., ŞEN G., ÇAPAR S., Senel S., DALKILIÇ H. E., et al.

Journal of Clinical Medicine , cilt.13, sa.23, 2024 (SCI-Expanded, Scopus)

2. Conscious Awareness-Based Breathing Method on Perceived Stress, Salivary Cortisol Level and Alcohol Craving

Schareck G., Çapar S., Schareck W.

ADDICTA-THE TURKISH JOURNAL ON ADDICTIONS , cilt.11, sa.3, ss.249-256, 2024 (ESCI, Scopus) Sürdürülebilir Kalkınma

3. Ata method’s performance in the M4 competition

ÇAPAR S., TAYLAN SELAMLAR H., YAVUZ İ., Taylan A. S., YAPAR G.

Hacettepe Journal of Mathematics and Statistics , cilt.52, sa.1, ss.268-276, 2023 (SCI-Expanded, Scopus)

4. The impact of smoking on response to tumor necrosis factor-α inhibitor treatment in patients with ankylosing spondylitis

Tuğsal H., Artın G., Can G., Çapar S., Zengin B., Akar S., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.53, sa.4, ss.970-978, 2023 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

5. Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort

GÜLLE S., KARAKAŞ A., CAN G., Senel S., ÇAPAR S., DALKILIÇ H. E., et al.

ARTHRITIS & RHEUMATOLOGY , ss.843-845, 2022 (SCI-Expanded, Scopus)

6. The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort

USLU S., GÜLLE S., CAN G., Senel S., ÇAPAR S., DALKILIÇ H. E., et al.

ARTHRITIS & RHEUMATOLOGY , ss.847-849, 2022 (SCI-Expanded, Scopus)

7. A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry

Önen F., Can G., Çapar S., Dalkılıç E., Pehlivan Y., Şenel S., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.9, sa.2, ss.82-87, 2022 (ESCI, TRDizin) Sürdürülebilir Kalkınma

8. Optimizing Type-I (α) and Type-II (β) Error Probabilities by Game-Theoretic Linear Programming for Sequential Sampling Plans in Quality Control

Sahinoglu M., Capar S.

International Journal of Computer Theory and Engineering , cilt.14, sa.1, ss.27-38, 2022 (Scopus)

9. Turkish STEM Teachers'Opinions aboutthe Scientist-Teacher-Student Partnership

ÇAVAŞ B., ÇAPAR S., ÇAVAŞ L., YAHŞİ Ö.

Journal of Turkish Science Education , cilt.18, sa.4, ss.622-637, 2021 (Scopus, TRDizin)

10. ATA method

YAPAR G., TAYLAN SELAMLAR H., ÇAPAR S., YAVUZ İ.

HACETTEPE JOURNAL OF MATHEMATICS AND STATISTICS , cilt.48, sa.6, ss.1838-1844, 2019 (SCI-Expanded, Scopus, TRDizin)

11. The Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results from the Turkbio Registry

Uslu S., CAN G., Senel S., DALKILIÇ H. E., Inanc N., Akars S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

12. The Effect of Smoking on Response to Tumour Necrosis Factor-Alpha Inhibitor Treatment in Psoriatic Arthritis Patients: Results from the TURKBIO Registry

Yarkan H., Kenar G., ÇAPAR S., CAN G., Zengin B., AKAR S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

13. Modified Holt's Linear Trend Method

YAPAR G., ÇAPAR S., TAYLAN SELAMLAR H., YAVUZ İ.

HACETTEPE JOURNAL OF MATHEMATICS AND STATISTICS , cilt.47, sa.5, ss.1394-1403, 2018 (SCI-Expanded, Scopus, TRDizin)

14. Phenotype Differences in HLA-B27 Positive Versus Negative Patients with Ankylosing Spondylitis in a Population That Show Relatively Weaker Association with HLA-B27

Yarkan H., Li Z., Kenar G., ÇAPAR S., Capa F., Steffensen R., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus)

15. Importance of Initial Value in Exponential Smoothing Methods

ÇAPAR S.

Dokuz Eylül Üniversitesi Sosyal Bilimler Enstitüsü Dergisi , cilt.17, sa.3, ss.291-302, 2016 (TRDizin)

16. ASDAS Can be Reliably Calculated When Only the Patient's Overall Basdai Score Is Available, but Not the Score(S) of Its Individual Component(S)

Cetin P., Kenar G., ÇAPAR S., Yarkan H., Zengin B., SARI İ., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

17. The Burden of Axial Spondyloarthritis: A Comparison of the Radiographic and Non-Radiographic Groups

Kenar G., Cetin P., CAN G., ÇAPAR S., Yarkan H., SARI İ., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

18. The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry

Ertenli I., KARADAĞ Ö., PEHLİVAN Y., DALKILIÇ H. E., Onat A. M., Kisacik B., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

19. Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis

Birlik M., ÇAPAR S., Akar S., SARI İ., ÖNEN F., Akkoc N.

ARCHIVES OF RHEUMATOLOGY , cilt.30, sa.3, ss.206-213, 2015 (SCI-Expanded, Scopus, TRDizin)

20. THE BURDEN OF AXIAL SPONDYLOARTHRITIS: A COMPARISON OF THE RADIOGRAPHIC AND NON-RADIOGRAPHIC GROUPS

Cetin P., Sen G., ÇAPAR S., Yarkan H., Kenar G., SARI İ., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.507, 2015 (SCI-Expanded, Scopus)

21. ASDAS CAN BE RELIABLY CALCULATED WHEN ONLY THE PATIENT'S OVERALL BASDAI SCORE IS AVAILABLE, BUT NOT THE SCORE(S) OF ITS INDIVIDUAL COMPONENT(S)

Cetin P., Kenar G., ÇAPAR S., Yarkan H., Zengin B., SARI İ., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.753, 2015 (SCI-Expanded, Scopus)

22. An algorithm for mean residual life computation of (n - k + 1)-out-of-n systems: An application of exponentiated Weibull distribution

GÜRLER S., ÇAPAR S.

APPLIED MATHEMATICS AND COMPUTATION , cilt.217, sa.19, ss.7806-7811, 2011 (SCI-Expanded, Scopus)

23. A retrospective evaluation of analgesic exposures from Izmir, Turkey

Hocaoğlu Aksay N., Kalkan Ş., Arıcı M. A., Çapar S., Tunçok Y.

HUMAN & EXPERIMENTAL TOXICOLOGY , cilt.26, sa.8, ss.629-636, 2007 (SCI-Expanded, Scopus)

24. Pesticide poisonings reported to the drug and poison information center in Izmir, Turkey

Kalkan Ş., Erdoğan A., Aygören O., Çapar S., Tunçok Y.

VETERINARY AND HUMAN TOXICOLOGY , cilt.45, sa.1, ss.50-52, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Stochastic Bayes measures to compare forecast accuracy of software-reliability models

Sahinoglu M., Deely J., ÇAPAR S.

IEEE TRANSACTIONS ON RELIABILITY , cilt.50, sa.1, ss.92-97, 2001 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 67

1. Investigation and Comparison of Artificial Neural Networks Models for Price Prediction in the Food Industry

Aksüngü S., Çapar S.

International Symposium Series on Graduate Researches 2022, İzmir, Türkiye, 2 - 03 Aralık 2022, ss.1, (Yayınlanmadı)

2. Ankilozan spondilit hastalarında birinci basamak ve sonraki basamak tedavi olarak CT-P13’ün etkinliği ve güvenliği: TÜRKBİO veritabanı sonuçları

USLU S., GÜLLE S., CAN G., ÇAPAR S., ŞENEL S., DALKILIÇ H. E., et al.

Spondiloartritler 2022, İzmir, Türkiye, 22 - 25 Eylül 2022, (Özet Bildiri)

3. Ankilozan spondilit hastalarında birinci basamak ve sonraki basamak tedavi olarak Ct-P13’ün etkinliği ve güvenliği: TURKBİO veritabanı sonuçları.

USLU S., GÜLLE S., CAN G., ÇAPAR S., ŞENEL S., AKAR S., et al.

Spondiloartritler 2022, İzmir, Türkiye, 22 - 24 Eylül 2022, (Tam Metin Bildiri)

4. Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort

GÜLLE S., KARAKAŞ A., CAN G., ŞENEL S., ÇAPAR S., DALKILIÇ H. E., et al.

ACR/ARHP Annual Meeting, PENSİLVANYA, Amerika Birleşik Devletleri, 02 Haziran 2022, (Özet Bildiri)

5. The Efficacy and Safety of CT-P13 as First-line and Subsequent–line Therapy in Patients with Anklylosing Spondylitis: Real-Life Data from TURKBIO Cohort,

USLU S., GÜLLE S., CAN G., ŞENEL S., ÇAPAR S., DALKILIÇ H. E., et al.

ACR/ARHP Annual Meeting, PENSİLVANYA, Amerika Birleşik Devletleri, 02 Haziran 2022, (Özet Bildiri)

6. PREVALENCE OF GASTROPROPHYLAXIS IN PATIENTS AGED 65 AND OVER REGISTERED IN PENSION IN TURKEY

CAN G., BİRLİK A. M., SARI İ., ÇAPAR S., AKIN D., SAVRAN Y., et al.

4TH INTERNATIONAL “BAŞKENT” CONGRESS ON PHYSICAL, SOCIAL AND HEALTH SCIENCES, Ankara, Türkiye, 27 - 28 Şubat 2022, (Tam Metin Bildiri)

7. Yapay Sinir Ağlarında Dengesiz Veri Setleri

UĞUR S., VAHAPLAR A., ÇAPAR S.

International Symposium of Scientific Research and Innovative Studies, Bandırma, Türkiye, 22 Şubat 2021, (Özet Bildiri)

8. The effect of smoking on response to tumor necrosis factor-alpha inhibitor treatment in psoriatic arthritis patients: Results from the TURKBIO registry.

YARKAN H., KENAR G., ÇAPAR S., CAN G., ZENGİN B., AKAR S., et al.

ACR/ARHP 2018, Şikago, Amerika Birleşik Devletleri, 19 - 24 Ekim 2018, cilt.70, ss.1-3584, (Tam Metin Bildiri)

9. Türk ankilozan spondilit hastalarında HLA B27 pozitifliğinin hastalık fenotipine etkisi

Yarkan H., Çapar S., Çapa F., Steffensen R., Li Z., Akar S., et al.

17. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Eylül 2018, (Tam Metin Bildiri)

10. Ankilozan spondilit Hastalarında Tümör Nekroz Faktör Alfa İnhibitör Tedavi Yanıtına Sigaranın Etkisi: Türkbio Veritabanı Sonuçları

Yarkan H., Can G., Çapar S., Zengin B., Kenar Artın G., Akar S., et al.

19. Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, cilt.10, (Tam Metin Bildiri)

11. Enflamatuvar romatizmal hastalıklarda orijinal referans infliksimab ile karşılaştırılan biyobenzer infliksimabın (CT-P13) etkinliği ve ilaçta sağkalımı: TÜRK-B‹O veritabanı

Uslu S., Can G., Şenel A. S., Dalkılıç H. E., İnanç G. N., Kocaer S. B., et al.

XIX. Ulusal Romatoloji Kongresi , Muğla, Türkiye, 26 - 30 Eylül 2018, cilt.10, ss.99-100, (Özet Bildiri)

12. The Effect of Smoking on Response to Tumor Necrosis Factor-Alpha Inhibitor Treatment in Ankylosing Spondylitis Patients: Results from the TURKBIO Registry

YARKAN TUĞSAL H., Can G., ÇAPAR S., Zengin B., KENAR ARTIN G., Akar S., et al.

Annual Meeting of the American-College-of-Rheumatology (ACR) and Association-for-Rheumatology-Health-Professionals (ARHP), Illinois, Amerika Birleşik Devletleri, 19 - 24 Ekim 2018, cilt.70, (Özet Bildiri)

13. THE EFFECT OF SMOKING ON RESPONSE TO TUMOR NECROSIS FACTOR-ALPHA INHIBITOR TREATMENT IN ANKYLOSING SPONDYLITIS PATIENTS: RESULTS FROM THE TURKBIO REGISTRY

Tugsal H. Y., Can G., Çapar S., Zengin B., Kenar G., Akar S., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.953, (Özet Bildiri)

14. ACUTE PHASE REACTANT CHANGE IN ANKYLOSING SPONDYLITIS PATIENTS

Aydemir F. D., Kenar G., Zengin B., Tugsal H. Y., ÇAPAR S., Birlik M., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1558, (Özet Bildiri)

15. THE EFFICACY AND DRUG SURVIVAL OF THE BIOSIMILAR INFLIXIMAB (CT-P13) COMPARED TO THE ORIGINAL REFERENCE INFLIXIMAB IN INFLAMMATORY RHEUMATIC DISEASES; RESULTS FROM THE TURKBIO REGISTRY

Uslu S., Can G., Senel S., DALKILIÇ H. E., Inanc N., Akar S., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.329, (Özet Bildiri)

16. SIMILAR EFFICACY OF TOFACITINIB ON DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS WITH AND WITHOUT PREVIOUS BIOLOGICALS; RESULTS FROM THE TURKBIO REGISTRY

Zengin B., Inanc N., Akar S., Can G., DALKILIÇ H. E., TUFAN A., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1401-1402, (Özet Bildiri)

17. Non-Steroid Anti-Inflamatuvar Ilaçların Kullanımı ve Yıllara Göre Değişimi

AKIN D., BİRLİK A. M., ÇAPAR S., AKAR S., SARI İ., CAN G., et al.

7. INTERNATIONAL TRAKYA FAMILY MEDİCİNE CONGRESS, Edirne, Türkiye, 21 - 25 Mart 2018, (Tam Metin Bildiri)

18. Phenotype Differences in HLA-B27 Positive Versus Negative Patients with Ankylosing Spondylitis in a Population That Show Relatively Weaker Association with HLA-B27.

Yarkan H., Li Z., Kenar Artın G., Çapar S., Çapa F., Steffensen R., et al.

American College of Rheumatology (ACR/ARHP) 2017 Annual Meeting, California, Amerika Birleşik Devletleri, 3 - 08 Kasım 2017, (Tam Metin Bildiri)

19. Phenotype Differences in HLA-B27 Positive Versus Negative Patients with Ankylosing Spondylitis in a Population That Show Relatively Weaker Association with HLA-B27

YARKAN H., Zhixiu L., KENAR G., ÇAPAR S., ÇAPA F., Steffensen R., et al.

Annual Meeting of the American College of Rheumatology, ACR/ARHP, 3 - 08 Kasım 2017, (Tam Metin Bildiri)

20. INHIBITING STAT SIGNALING PATHWAYS AS A POSSIBLE THERAPY TO MODULATE SYNOVIAL INFLAMMATION IN OSTEOARTHRITIS

Suijkerbuijk M. A., ÇAPAR S., Kops N., Meuffels D. E., van Osch G. J., Bastiaansen-Jenniskens Y. M.

World Congress of the Osteoarthritis-Research-Society-International (OARSI) on Osteoarthritis, Nevada, Amerika Birleşik Devletleri, 27 - 30 Nisan 2017, cilt.25, (Özet Bildiri)

21. Türk ankilozan spondilit hastalarında HLA B27 pozitifliğinin hastalık fenotipine etkisi

Yarkan Tuğsal H., Çapar S., Çapa F., Steffensen R., Li Z., Akar S., et al.

XVII. Ulusal Romatololji Kongresi, Antalya, Türkiye, 24 - 30 Ekim 2016, cilt.8, ss.16-17, (Özet Bildiri)

22. Modified Holt’s Linear Trend Method

selamlar h. t., YAPAR G., ÇAPAR S., YAVUZ İ.

36 th International Symposium on Forecasting, 19 - 22 Haziran 2016, (Özet Bildiri)

23. Modified Holt’xxs Linear Trend Method

TAYLAN H., YAPAR G., ÇAPAR S., YAVUZ İ.

36th International Symposium on Forecasting, İspanya, 18 Haziran 2016, (Özet Bildiri)

24. The Burden of Axial Spondyloarthritis: A Comparison of the Radiographic and Non-Radiographic Groups.

KENAR ARTIN G., ÇETİN P., CAN G., ÇAPAR S., YARKAN H., SARI İ., et al.

American College of Rheumatology (ACR/ARHP) 2015 Annual Meeting, Amerika Birleşik Devletleri, 16 - 11 Kasım 2015, (Tam Metin Bildiri)

25. The Effect of Rheumatoid Factor and Anti Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care The Results from Turkbio Registry

ERTENLİ A. İ., KARADAĞ Ö., PEHLİVAN Y., DALKILIÇ H. E., ONAT A. M., KISACIK B., et al.

2015 ACR/ARHP Annual Meeting, 7 - 11 Kasım 2015, cilt.67, (Özet Bildiri)

26. The Burden of Axial Spondyloarthritis A Comparison of theRadiographic and Non Radiographic Groups

gökçe k., çetin p., CAN G., ÇAPAR S., SARI İ., handan y., et al.

2015 ACR/ARHP Annual Meeting, 7 - 11 Kasım 2015, cilt.67, (Özet Bildiri)

27. ASDAS Can be Reliably Calculated When Only the Patient's Overall Basdai Score Is Available, but Not the Score(S) of Its Individual Component(S)

ÇETİN P., KENAR ARTIN G., ÇAPAR S., YARKAN H., ZENGİN B., SARI İ., et al.

American College of Rheumatology (ACR/ARHP) 2015 Annual Meeting, Amerika Birleşik Devletleri, 6 - 11 Kasım 2015, (Tam Metin Bildiri)

28. SAT0261 Asdas can be Reliably Calculated When Only the Patient s Overall Basdai Score is Available but not the Score S of its Individual Component S Table 1

Çetin P., Kenar G., ÇAPAR S., Handan Y., Zengin B., SARI İ., et al.

EULAR 2015, 10 - 13 Haziran 2015

29. ASDAS can be reliably calculated when only the patient's overall BASDAI score is available, but not the score(s) of its individual component(s).

ÇETİN P., KENAR ARTIN G., ÇAPAR S., YARKAN H., ZENGİN B., SARI İ., et al.

Congress of Rheumatology (EULAR) Ann Rheum Dis volume 74, Suppl 2, year 2015 page 253., ROMA, İtalya, 10 - 13 Haziran 2015, cilt.74, ss.253, (Tam Metin Bildiri)

30. The burden of axial spondyloarthritis: a comparison of the radiographic and non-radiographic groups

ÇETİN P., CAN G., ÇAPAR S., YARKAN H., KENAR ARTIN G., SARI İ., et al.

Congress of Rheumatology (EULAR) 2015, ROMA, İtalya, 10 - 13 Haziran 2015, cilt.74, ss.507, (Özet Bildiri)

31. THE BURDEN OF AXIAL SPONDYLOARTHRITIS: A COMPARISON OF THE RADIOGRAPHIC AND NON-RADIOGRAPHIC GROUPS

Çetin P., Can G., Çapar S., Yarkan Tuğsal H., Kenar G., Sarı İ., et al.

Annual European Congress of Rheumatology EULAR 2015, Rome, İtalya, 10 - 13 Haziran 2015, cilt.74, ss.507, (Özet Bildiri)

32. COMPARISON OF LONG-TERM DRUG SURVIVAL OF TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: A SINGLE CENTER TURKISH EXPERIENCE OVER A DECADE

ŞEN G., ÇAPAR S., ÇETİN P., SOLMAZ D., KENAR G., YARKAN H., et al.

15. Annual European Congress of Rheumatology, Roma, İtalya, 10 - 14 Haziran 2015, (Özet Bildiri)

33. COMPARISON OF LONG TERM DRUG SURVIVAL OF TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS A SINGLE CENTER TURKISH EXPERIENCE OVER A DECADE

Can G., Çapar S., Çetin P., Solmaz D., Gökçe K., Handan Y., et al.

Annual European Congress of Rheumatology EULAR 2015, Rome, İtalya, 10 - 13 Haziran 2015, cilt.74, ss.1275, (Özet Bildiri)

34. ACCURACY OF MODIFIED EXPONENTIAL SMOOTHING ETHOD OR M COMPETITION 111 SERIES

YAPAR G., TAYLAN H., ÇAPAR S.

The 8th Conference of Eastern Mediterranean Region of International Biometric Society, 11 - 15 Mayıs 2015, (Özet Bildiri)

35. Accuracy of Modified Exponential Smoothing Method for M-Competition 111-series

YAPAR G., TAYLAN H., ÇAPAR S.

The 8th Conference of EMR-IBS, Nevşehir, Türkiye, 15 Mayıs 2015, (Özet Bildiri)

36. EKSİK BASDAI VERİLERİ OLMASI DURUMUNDA ASDAS HESAPLAMASI

Çetin P., Çapar S., Kenar G., Yarkan Tuğsal H., Zengin B., Sarı İ., et al.

XV. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 29 Ekim - 02 Kasım 2014, ss.32, (Özet Bildiri)

37. Kadınlarda Zehirlenme Dokuz Eylül Üniversitesi İlaç Ve Zehir Danışma Merkezi 2007 Yılı Verilerinin İstatistiksel Değerlendirmesi

Yıldıztepe E., Çapar S., Tunçok Y., Arıcı M. A.

International Multidisciplinary Women Congress, İzmir, Türkiye, 13 - 16 Ekim 2009, cilt.2, ss.835-840, (Tam Metin Bildiri)

38. RHEUMATOID ARTHRITIS PRESCRIBING PATTERNS AND HEALTH ECONOMIC OUTCOMES IN TURKEY:

Akkoç N., Çapar S., Akar S., Can G., Birlik A. M., Önen F.

Annual European Congress of Rheumatology EULAR 2009, Kobenhavn, Danimarka, 10 - 13 Haziran 2009, cilt.68, ss.742, (Özet Bildiri)

39. Emekli Sandığı Veri Tabanının Analizine Göre 2000 ve 2005 Yılları Arasında Romatoid Artritte Reçeteleme Paternleri

AKKOÇ N., ÇAPAR S., AKAR S., BİRLİK A. M., CAN G., ÖNEN F.

IX. Ulusal Romatoloji Kongresi- 2008, Antalya, Türkiye, 11 - 15 Ekim 2008, (Tam Metin Bildiri)

40. Emekli Sandığı Veri Tabanı Analizine Göre 2000 ve 2005 Yılları Arasında Romatoid Artritte Reçeteleme Paternleri

AKKOÇ N., ÇAPAR S., AKAR S., BİRLİK A. M., CAN G., ÖNEN F.

IX. Ulusal Romatoloji Kongresi, Türkiye, 11 - 15 Ekim 2008

41. Non-Steroidal Anti-Inflammatory Drug (NSAID) Prescription Preferences Among Chronic Rofecoxib Users After Rofecoxib Withdrawal

Birlik A. M., Savran Y., Can G., Çapar S., Akar S., Sarı İ., et al.

2007 ACR/ARHP Annual Meeting, Massachusetts, Amerika Birleşik Devletleri, 6 - 11 Kasım 2007, (Özet Bildiri)

42. The prevalence of gastroprophylaxis (GP) and gastroprotective drug prescribing patterns in high-risk nonsteroidal antiinflammatory drug (NSAID) users in Turkey

Can G., Birlik M., Aker S., SARI İ., ÇAPAR S., Akin D., et al.

Annual European Congress of Rheumatology (EULAR 2007), Barcelona, İspanya, 13 - 16 Haziran 2007, cilt.66, ss.542-543, (Özet Bildiri)

43. Effectiveness of national consensus recommendations in preventing reactivation of latent tuberculosis in patients treated with TNF inhibitors

Birlik M., Akar S., ÇAPAR S., Ozmen M., SARI İ., Can G., et al.

Annual European Congress of Rheumatology (EULAR 2007), Barcelona, İspanya, 13 - 16 Haziran 2007, cilt.66, ss.161-162, (Özet Bildiri) Sürdürülebilir Kalkınma

44. THE PROPORTIONS OF MILD, MODERATE AND SEVERE NSAID USERS AND A LOW PERCENTAGE OF GASTRIC PROTECTION IN ELDERLY TURKISH PATIENTS

Can G., Birlik A. M., Akar S., Sarı İ., Çapar S., Akın D., et al.

Annual European Congress of Rheumatology EULAR 2007, Barcelona, İspanya, 13 - 16 Haziran 2007, cilt.66, ss.626, (Özet Bildiri)

45. EFFECTIVENESS OF NATIONAL CONSENSUS RECOMMENDATIONS IN PREVENTING REACTIVATION OF LATENT TUBERCULOSIS IN PATIENTS TREATED WITH TNF INHIBITORS

Birlik A. M., Akar S., Çapar S., Özmen M., Sarı İ., Can G., et al.

Annual European Congress of Rheumatology EULAR 2007, Barcelona, İspanya, 13 - 16 Haziran 2007, cilt.66, ss.161, (Özet Bildiri) Sürdürülebilir Kalkınma

46. NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) PRESCRIPTION PREFERENCES AMONG CHRONIC ROFECOXIB USERS AFTER ROFECOXIB WITHDRAWAL

Birlik A. M., Savran Y., Can G., Çapar S., Akar S., Sarı İ., et al.

Annual European Congress of Rheumatology EULAR 2007, Barcelona, İspanya, 13 - 16 Haziran 2007, cilt.66, ss.626, (Özet Bildiri)

47. Kronik Rofekoksib Kullanıcılarında Rofekoksib Sonrası Nonsteroid Anti-İnflamatuar İlaç Tercihleri

SAVRAN Y., BİRLİK A. M., ÇAPAR S., SARI İ., ŞEN G., ÖNEN F., et al.

Ulusal Romatoloji Kongresi, Türkiye, 1 - 05 Eylül 2006

48. Türkiye’de Emekli Sandığına Kayıtlı 65 Yaş ve Üzeri Hastalarda Gastroprofilaksi Sıklığı

CAN G., BİRLİK A. M., SARI İ., ÇAPAR S., AKIN D., SAVRAN Y., et al.

Ulusal Romatoloji Kongresi, Türkiye, 1 - 05 Eylül 2006

49. Biyolojik ajan Kullanan Hastalarda Tüberküloz Proflaksisi İçin Oluşturulan Konsensus Raporunun Latent Tüberküloz Tedavisi ve Tüberküloz Riski Üzerindeki Etkisi

AKKOÇ N., BİRLİK A. M., ÇAPAR S., SARI İ., AKAR S., ÖNEN F.

Ulusal Romatoloji Kongresi, Türkiye, 1 - 05 Eylül 2006 Sürdürülebilir Kalkınma

50. Emekli Sandığına Kayıtlı 65 Yaş ve Üzeri Hastalarda Hafif, Orta, Ağır NSAİİ Kullanımı ve Gastroproflaksi İlişkisi

CAN G., BİRLİK A. M., SARI İ., ÇAPAR S., AKIN D., SAVRAN Y., et al.

Ulusal Romatoloji Kongresi, Türkiye, 1 - 05 Eylül 2006

51. How does the use of NSAIDs and glucocorticoids change in rheumatoid arthritis patients different time intervals after anti-TNF therapy with.

Birlik M., Akar S., ÇAPAR S., Gurler O., SARI İ., Onen F., et al.

70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 Kasım 2006, cilt.54, (Özet Bildiri)

52. How does the use of nsaids and glucocorticoids change in rheumatoid arthritis patients different time intervals after anti-TNF therapy with

Birlik M., Akar S., ÇAPAR S., Gurler O., SARI İ., Onen F., et al.

Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.336, (Özet Bildiri)

53. Tuberculosis in patients on anti-TNF therapy in Turkey

Akkoc N., SARI İ., Akar S., Birlik M., ÇAPAR S., Onen F.

Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.499-500, (Özet Bildiri) Sürdürülebilir Kalkınma